Clinical Trial Update: Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial [NA]

View source ↗

Summary

A prospective randomized trial evaluating thiotepa in combination with melphalan as conditioning therapy for autologous stem cell transplantation in multiple my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Alkeran (melphalan)
• TEPADINA (THIOTEPA)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Multiple Myeloma | NA | Status: NOT_YET_RECRUITING